American International Group’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,677
| Closed | -$47 | – | 3182 |
|
|
2021
Q1 | $47 | Buy |
21,677
+58
| +0.3% | – | ﹤0.01% | 2997 |
|
|
2020
Q4 | $48 | Sell |
21,619
-622
| -3% | -$1 | ﹤0.01% | 2971 |
|
|
2020
Q3 | $59K | Sell |
22,241
-505
| -2% | -$1.34K | ﹤0.01% | 2820 |
|
|
2020
Q2 | $70K | Sell |
22,746
-966
| -4% | -$2.97K | ﹤0.01% | 2739 |
|
|
2020
Q1 | $46K | Sell |
23,712
-1,370
| -5% | -$2.66K | ﹤0.01% | 2710 |
|
|
2019
Q4 | $72K | Sell |
25,082
-212
| -0.8% | -$609 | ﹤0.01% | 2771 |
|
|
2019
Q3 | $93K | Buy |
25,294
+4,788
| +23% | +$17.6K | ﹤0.01% | 2652 |
|
|
2019
Q2 | $85K | Buy |
+20,506
| New | +$85K | ﹤0.01% | 2761 |
|
|
2016
Q2 | – | Sell |
-349,425
| Closed | -$500K | – | 3583 |
|
|
2016
Q1 | $500K | Buy |
349,425
+79,500
| +29% | +$114K | ﹤0.01% | 2013 |
|
|
2015
Q4 | $443K | Buy |
269,925
+32,000
| +13% | +$52.5K | ﹤0.01% | 2133 |
|
|
2015
Q3 | $557K | Buy |
237,925
+44,300
| +23% | +$104K | ﹤0.01% | 1922 |
|
|
2015
Q2 | $529K | Buy |
193,625
+19,523
| +11% | +$53.3K | ﹤0.01% | 2127 |
|
|
2015
Q1 | $583K | Buy |
174,102
+161,775
| +1,312% | +$542K | ﹤0.01% | 2030 |
|
|
2014
Q4 | $42.8K | Buy |
12,327
+552
| +5% | +$1.92K | ﹤0.01% | 4037 |
|
|
2014
Q3 | $59.2K | Sell |
11,775
-9
| -0.1% | -$45 | ﹤0.01% | 3896 |
|
|
2014
Q2 | $163K | Buy |
+11,784
| New | +$163K | ﹤0.01% | 3171 |
|